The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
The global Drug Delivery Devices market was valued at US$ 41390 million in 2023 and is anticipated to reach US$ 58080 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Devices.
Report Scope
The Drug Delivery Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Cipla
- Baxter International
- Nipro Corporation
- Roche
- Boehringer Ingelheim
- Allergan
- 3M
- BD
- Catalent
- Valeant Pharmaceuticals
- Bayer AG
- Chiesi
- Phillips-Medisize
- Johnson & Johnson
- Shandong Weigao
- Pfizer
- B.Braun
- Novartis AG
- Zhengkang
- Gerresheimer
- COVIDIEN Medtronic
- Schott forma vitrum
- Alkermes
- Skyepharma
Segment by Type
- Injection Type
- Mucosal Type
- Implanted Type
- Others Type
Segment by Application
- Pharmaceutical Companies
- Hospitals
- Clinics
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Devices Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injection Type
1.2.3 Mucosal Type
1.2.4 Implanted Type
1.2.5 Others Type
1.3 Market by Application
1.3.1 Global Drug Delivery Devices Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Devices Market Perspective (2019-2030)
2.2 Drug Delivery Devices Growth Trends by Region
2.2.1 Global Drug Delivery Devices Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Delivery Devices Historic Market Size by Region (2019-2024)
2.2.3 Drug Delivery Devices Forecasted Market Size by Region (2025-2030)
2.3 Drug Delivery Devices Market Dynamics
2.3.1 Drug Delivery Devices Industry Trends
2.3.2 Drug Delivery Devices Market Drivers
2.3.3 Drug Delivery Devices Market Challenges
2.3.4 Drug Delivery Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Devices Players by Revenue
3.1.1 Global Top Drug Delivery Devices Players by Revenue (2019-2024)
3.1.2 Global Drug Delivery Devices Revenue Market Share by Players (2019-2024)
3.2 Global Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery Devices Revenue
3.4 Global Drug Delivery Devices Market Concentration Ratio
3.4.1 Global Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Devices Revenue in 2023
3.5 Drug Delivery Devices Key Players Head office and Area Served
3.6 Key Players Drug Delivery Devices Product Solution and Service
3.7 Date of Enter into Drug Delivery Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Devices Breakdown Data by Type
4.1 Global Drug Delivery Devices Historic Market Size by Type (2019-2024)
4.2 Global Drug Delivery Devices Forecasted Market Size by Type (2025-2030)
5 Drug Delivery Devices Breakdown Data by Application
5.1 Global Drug Delivery Devices Historic Market Size by Application (2019-2024)
5.2 Global Drug Delivery Devices Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Delivery Devices Market Size (2019-2030)
6.2 North America Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Delivery Devices Market Size by Country (2019-2024)
6.4 North America Drug Delivery Devices Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery Devices Market Size (2019-2030)
7.2 Europe Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Delivery Devices Market Size by Country (2019-2024)
7.4 Europe Drug Delivery Devices Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Devices Market Size (2019-2030)
8.2 Asia-Pacific Drug Delivery Devices Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Delivery Devices Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Delivery Devices Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery Devices Market Size (2019-2030)
9.2 Latin America Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Delivery Devices Market Size by Country (2019-2024)
9.4 Latin America Drug Delivery Devices Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Devices Market Size (2019-2030)
10.2 Middle East & Africa Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Delivery Devices Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Delivery Devices Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cipla
11.1.1 Cipla Company Detail
11.1.2 Cipla Business Overview
11.1.3 Cipla Drug Delivery Devices Introduction
11.1.4 Cipla Revenue in Drug Delivery Devices Business (2019-2024)
11.1.5 Cipla Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Detail
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Drug Delivery Devices Introduction
11.2.4 Baxter International Revenue in Drug Delivery Devices Business (2019-2024)
11.2.5 Baxter International Recent Development
11.3 Nipro Corporation
11.3.1 Nipro Corporation Company Detail
11.3.2 Nipro Corporation Business Overview
11.3.3 Nipro Corporation Drug Delivery Devices Introduction
11.3.4 Nipro Corporation Revenue in Drug Delivery Devices Business (2019-2024)
11.3.5 Nipro Corporation Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Drug Delivery Devices Introduction
11.4.4 Roche Revenue in Drug Delivery Devices Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Drug Delivery Devices Introduction
11.5.4 Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Drug Delivery Devices Introduction
11.6.4 Allergan Revenue in Drug Delivery Devices Business (2019-2024)
11.6.5 Allergan Recent Development
11.7 3M
11.7.1 3M Company Detail
11.7.2 3M Business Overview
11.7.3 3M Drug Delivery Devices Introduction
11.7.4 3M Revenue in Drug Delivery Devices Business (2019-2024)
11.7.5 3M Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Drug Delivery Devices Introduction
11.8.4 BD Revenue in Drug Delivery Devices Business (2019-2024)
11.8.5 BD Recent Development
11.9 Catalent
11.9.1 Catalent Company Detail
11.9.2 Catalent Business Overview
11.9.3 Catalent Drug Delivery Devices Introduction
11.9.4 Catalent Revenue in Drug Delivery Devices Business (2019-2024)
11.9.5 Catalent Recent Development
11.10 Valeant Pharmaceuticals
11.10.1 Valeant Pharmaceuticals Company Detail
11.10.2 Valeant Pharmaceuticals Business Overview
11.10.3 Valeant Pharmaceuticals Drug Delivery Devices Introduction
11.10.4 Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2019-2024)
11.10.5 Valeant Pharmaceuticals Recent Development
11.11 Bayer AG
11.11.1 Bayer AG Company Detail
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Drug Delivery Devices Introduction
11.11.4 Bayer AG Revenue in Drug Delivery Devices Business (2019-2024)
11.11.5 Bayer AG Recent Development
11.12 Chiesi
11.12.1 Chiesi Company Detail
11.12.2 Chiesi Business Overview
11.12.3 Chiesi Drug Delivery Devices Introduction
11.12.4 Chiesi Revenue in Drug Delivery Devices Business (2019-2024)
11.12.5 Chiesi Recent Development
11.13 Phillips-Medisize
11.13.1 Phillips-Medisize Company Detail
11.13.2 Phillips-Medisize Business Overview
11.13.3 Phillips-Medisize Drug Delivery Devices Introduction
11.13.4 Phillips-Medisize Revenue in Drug Delivery Devices Business (2019-2024)
11.13.5 Phillips-Medisize Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Detail
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Drug Delivery Devices Introduction
11.14.4 Johnson & Johnson Revenue in Drug Delivery Devices Business (2019-2024)
11.14.5 Johnson & Johnson Recent Development
11.15 Shandong Weigao
11.15.1 Shandong Weigao Company Detail
11.15.2 Shandong Weigao Business Overview
11.15.3 Shandong Weigao Drug Delivery Devices Introduction
11.15.4 Shandong Weigao Revenue in Drug Delivery Devices Business (2019-2024)
11.15.5 Shandong Weigao Recent Development
11.16 Pfizer
11.16.1 Pfizer Company Detail
11.16.2 Pfizer Business Overview
11.16.3 Pfizer Drug Delivery Devices Introduction
11.16.4 Pfizer Revenue in Drug Delivery Devices Business (2019-2024)
11.16.5 Pfizer Recent Development
11.17 B.Braun
11.17.1 B.Braun Company Detail
11.17.2 B.Braun Business Overview
11.17.3 B.Braun Drug Delivery Devices Introduction
11.17.4 B.Braun Revenue in Drug Delivery Devices Business (2019-2024)
11.17.5 B.Braun Recent Development
11.18 Novartis AG
11.18.1 Novartis AG Company Detail
11.18.2 Novartis AG Business Overview
11.18.3 Novartis AG Drug Delivery Devices Introduction
11.18.4 Novartis AG Revenue in Drug Delivery Devices Business (2019-2024)
11.18.5 Novartis AG Recent Development
11.19 Zhengkang
11.19.1 Zhengkang Company Detail
11.19.2 Zhengkang Business Overview
11.19.3 Zhengkang Drug Delivery Devices Introduction
11.19.4 Zhengkang Revenue in Drug Delivery Devices Business (2019-2024)
11.19.5 Zhengkang Recent Development
11.20 Gerresheimer
11.20.1 Gerresheimer Company Detail
11.20.2 Gerresheimer Business Overview
11.20.3 Gerresheimer Drug Delivery Devices Introduction
11.20.4 Gerresheimer Revenue in Drug Delivery Devices Business (2019-2024)
11.20.5 Gerresheimer Recent Development
11.21 COVIDIEN Medtronic
11.21.1 COVIDIEN Medtronic Company Detail
11.21.2 COVIDIEN Medtronic Business Overview
11.21.3 COVIDIEN Medtronic Drug Delivery Devices Introduction
11.21.4 COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2019-2024)
11.21.5 COVIDIEN Medtronic Recent Development
11.22 Schott forma vitrum
11.22.1 Schott forma vitrum Company Detail
11.22.2 Schott forma vitrum Business Overview
11.22.3 Schott forma vitrum Drug Delivery Devices Introduction
11.22.4 Schott forma vitrum Revenue in Drug Delivery Devices Business (2019-2024)
11.22.5 Schott forma vitrum Recent Development
11.23 Alkermes
11.23.1 Alkermes Company Detail
11.23.2 Alkermes Business Overview
11.23.3 Alkermes Drug Delivery Devices Introduction
11.23.4 Alkermes Revenue in Drug Delivery Devices Business (2019-2024)
11.23.5 Alkermes Recent Development
11.24 Skyepharma
11.24.1 Skyepharma Company Detail
11.24.2 Skyepharma Business Overview
11.24.3 Skyepharma Drug Delivery Devices Introduction
11.24.4 Skyepharma Revenue in Drug Delivery Devices Business (2019-2024)
11.24.5 Skyepharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
